Pharmaceutical

Pfizer:

$15 billion in 1st quarter earnings, mostly from COVID vaccine

Profits during this period rose by 61 percent.

Triple-vaxxed pharma exec quits over vax mandate

Former Insmed exec resigns, telling company he would refuse to 'cheerlead for such an immoral and anti-science proposition.'

Pfizer's oral COVID-19 drug enters early trials

Pfizer's oral COVID-19 antiviral therapy drug could be given to patients at the first sign of infection, the drug maker said on Tuesday.

BigPharma poised to rake in $10 billion/year from COVID vaccine

Whereas some companies such as AstraZeneca have pledged to sell at cost, others plan to charge up to $37 per shot.

China Article V: We will never be quite the same again.

Series on China, Article IV: The ultimate aim of the China virus .

First cannabis inhaler unveiled by Tel Aviv pharma tech co.

The first metered-dose inhaler in the world is launched after 8 years of clinical trials and regulatory approval processes and $83 million.

Israeli Pharma Giant Teva Buys Botox's Allergan

$40.5 billion purchase solidifies Teva as world leader in generic drugs, after $40.1 billion bid for rival Mylan meets resistance.

Israeli Pharma Company Teva Looks to Become Global Giant

$40 billion acquisition of US company would launch Teva to unprecedented size - but will its bid be accepted?